title: [Kingella kingae spondylodiscitis in an adult].
authors.forename: V
authors.initials: V
authors.lastname: Ducoulombier
authors.forename: E
authors.initials: E
authors.lastname: Dehecq
authors.forename: H
authors.initials: H
authors.lastname: Luraschi
authors.forename: C
authors.initials: C
authors.lastname: Prudhomme
authors.forename: D
authors.initials: D
authors.lastname: Bessard
authors.forename: E
authors.initials: E
authors.lastname: Houvenagel
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D015299:Discitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D020802:Epidural Abscess / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000175:diagnosis; D017882:Kingella kingae / Q000302:isolation & purification*; D017116:Low Back Pain / Q000209:etiology; D008297:Male; D016870:Neisseriaceae Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013125:Spinal Neoplasms / Q000175:diagnosis
chemical_list: D000900:Anti-Bacterial Agents; D015242:Ofloxacin; D012293:Rifampin